Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             186 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Copyright 2019
 132 S1 p. ii
 artikel
2 OC-044 Are elderly HNSCC patients undertreated? An analysis of outcomes using the SEER-Medicare database Suzuki, I.
 2019
 132 S1 p. 23
 artikel
3 OC-009 Carbon-ion reirradiation for recurrent Head and Neck cancer: A single-institutional experience Held, T.
 2019
 132 S1 p. 9
 artikel
4 OC-041 DAHANCA 28a: Phase I/II study of acc. hyperfractionated RT, cisplatin and nimorazole in P16-LAHNSCC Saksoe, M.
 2019
 132 S1 p. 21-22
 artikel
5 OC-008 Fast tumor regression detected by weekly MRI allows for adaptive (chemo) radiation for Head and Neck cancer Terhaard, C.
 2019
 132 S1 p. 8-9
 artikel
6 OC-042 Genomic characterization of oral premalignant lesions to identify high-risk molecular clusters Bossi, P.
 2019
 132 S1 p. 22
 artikel
7 OC-043 HNSCC in elderly frail patients treated by hafnium oxide nanoparticles activated by IMRT Hoffmann, C.
 2019
 132 S1 p. 22-23
 artikel
8 OC-006 Individualized prophylactic irradiation based on sentinel lymph node(s) identification in cN0 HNSCC Longton, E.
 2019
 132 S1 p. 7
 artikel
9 OC-010 Local recurrence of nasopharyngeal carcinomas outcomes after reirradiation Ruffier-Loubière, A.
 2019
 132 S1 p. 9-10
 artikel
10 OC-011 New insights from the De-ESCALate HPV trial Mehanna, H.
 2019
 132 S1 p. 10-11
 artikel
11 OC-040 Nomogram for cumulative cisplatin dose for LAHNC receiving tri-weekly high-dose cisplatin CCRT Wang, T.
 2019
 132 S1 p. 21
 artikel
12 OC-005 Preoperative vs. postoperative radiotherapy in treatment of oral cavity cancer - The ARTSCAN 2 study Carlwig, K.
 2019
 132 S1 p. 6
 artikel
13 OC-007 Radiologic extranodal extension portends worse outcome in TNM-8 cT1-T2N1 HPV+ oropharyngeal cancer Huang, S.H.S.
 2019
 132 S1 p. 7-8
 artikel
14 OC-023 Real life application of the PET-Neck protocol for post radiotherapy surveillance in advanced HNSCC Zhou, S.
 2019
 132 S1 p. 14-15
 artikel
15 OC-020 Sentinel lymph node biopsy for early stage oral cancer; experience of 3 Dutch Head and Neck centers Den Toom, I.
 2019
 132 S1 p. 12-13
 artikel
16 OC-045 Socioeconomic inequality in head and neck cancer survival- a population-based study from DAHANCA Olsen, M.H.
 2019
 132 S1 p. 23-24
 artikel
17 OC-021 Transoral Laser Microsurgery for T1a glottic cancer - DAHANCA 27 Lyhne, N.
 2019
 132 S1 p. 13
 artikel
18 OC-022 Unexpected drainage patterns and high accuracy of SLNB in OSCC after previous neck treatment Boeve, K.
 2019
 132 S1 p. 13-14
 artikel
19 OC-024 12 week PET-CTs have a low PPV for nodal residual disease in HPV positive oropharygeal cancers Rulach, R.
 2019
 132 S1 p. 14
 artikel
20 OC-019 What is the optimal cut-off of depth of invasion for elective neck dissection in oral cavity cancer? 2019
 132 S1 p. 12
 artikel
21 PD-031 CT-based Radiomics Predicting HPV Status in Head and Neck Squamous Cell Carcinoma Shi, Z.
 2019
 132 S1 p. 18-19
 artikel
22 PD-030 Does multiparametric imaging with FDG-PET/MRI capture intratumor heterogeneity in histopathology? Rasmussen, J.
 2019
 132 S1 p. 17-18
 artikel
23 PD-032 Incidence and management of laryngeal squamous cell carcinoma in the Nordic countries Haapaniemi, A.
 2019
 132 S1 p. 19
 artikel
24 PD-029 Phase II trial: melatonin oral gel for prevention of mucositis in oropharynx and oral cavity tumors Borbalas, A. Lozano
 2019
 132 S1 p. 16-17
 artikel
25 PO-054 Adaptive radiotherapy in head and neck cancers; Which patient group needs to be prioritised? Figen, M.
 2019
 132 S1 p. 29
 artikel
26 PO-173 Adenoid cystic carcinoma of the Head and Neck: demographics, prognostic features, and outcomes 2019
 132 S1 p. 92
 artikel
27 PO-175 Adjuvant therapy in patients older than 70ys with Head and Neck cancer (HNC): Turkish HNC Group study Metcalfe, E.
 2019
 132 S1 p. 92-93
 artikel
28 PO-102 Amplification of genes at 11q13 in relation to HPV status in head and neck squamous cell carcinomas Rodrigo, J.P.
 2019
 132 S1 p. 52
 artikel
29 PO-083 Analysis of received doses at organs of risk in SCCHN patients treated with postoperative VMAT-SIB Djan, I.
 2019
 132 S1 p. 43-44
 artikel
30 PO-087 Apatinib combined with oral chemotherapy in patients with recurrent/metastatic head and neck cancer Dou, S.
 2019
 132 S1 p. 45-46
 artikel
31 PO-053 A questionnaire-based survey on current management strategies for head and neck cancer in China Wu, C.
 2019
 132 S1 p. 28-29
 artikel
32 PO-179 A saliva-based assay to aid in the diagnosis of Oral Squamous Cell Carcinoma in a German Clinic Donovan, M.
 2019
 132 S1 p. 94-95
 artikel
33 PO-088 Assessment of acute toxicities in nasopharyngeal carcinoma with IMRT - A tale of two contours Pareek, V.
 2019
 132 S1 p. 46
 artikel
34 PO-059 Association of pretreatment nutritional status on outcome of radiotherapy in head and neck SCC Emarah, M.
 2019
 132 S1 p. 31-32
 artikel
35 PO-086 Buparlisib (AN2025) as a potential treatment for anti-PD-1 non-responding tumor Wang, J.
 2019
 132 S1 p. 45
 artikel
36 PO-107 CAFs secrete factors that sustain cancer stem properties in head and neck squamous carcinoma cells Rodrigo, J.P.
 2019
 132 S1 p. 54-55
 artikel
37 PO-092 Can Brachytherapy help reduce the dose to DARS in Head and Neck cancer? A Clinical experience Pareek, V.
 2019
 132 S1 p. 47-48
 artikel
38 PO-117 Can we reduce the posterior margins during irradiation of nasopharyngeal cancer? Farhat, L.
 2019
 132 S1 p. 60
 artikel
39 PO-172 Carbon ion radiotherapy in active raster- scanned technique for malignant lacrimal gland tumors Akbaba, S.
 2019
 132 S1 p. 91-92
 artikel
40 PO-064 Changes in target volumes and dosimetric impact during the IMRT treatment of NPC Daoud, H.
 2019
 132 S1 p. 34
 artikel
41 PO-058 Cisplatin, Fluorouracil, Docetaxel in Head and Neck Carcinoma: real data of induction chemotherapy Pereira, F. Ferreira
 2019
 132 S1 p. 31
 artikel
42 PO-134 Clinical and dosimetric predictors of oral mucositis in the treatment of head and neck cancer Arcadipane, F.
 2019
 132 S1 p. 71
 artikel
43 PO-09 Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic HNSCC Bonomo, P.
 2019
 132 S1 p. 50-51
 artikel
44 PO-108 Clinical relevance of Cortactin and Focal Adhesion Kinase as predictors of laryngeal cancer risk Rodrigo, J.P.
 2019
 132 S1 p. 55
 artikel
45 PO-103 Competing mortality in oropharyngeal carcinoma according to HPV status González, J.M. Costa
 2019
 132 S1 p. 53
 artikel
46 PO-071 Critical weight loss and feeding tube use in patients with HPV-positive oropharynx cancer Vangelov, B.
 2019
 132 S1 p. 37
 artikel
47 PO-122 CT /PET based dosiomics and radiomics model predicts local control of nasopharyngeal carcinoma Fanetti, G.
 2019
 132 S1 p. 62-63
 artikel
48 PO-163 Desmoid tumors of the Head and Neck Schrey, A.
 2019
 132 S1 p. 87
 artikel
49 PO-116 Diagnostic and prognostic impact of 18F-FDG PET/CT imaging in patients with nasopharyngeal carcinoma Esteve, J. Dura
 2019
 132 S1 p. 59-60
 artikel
50 PO-177 Different definitive Radiotherapy approaches in Indian elderly Head and Neck Cancer patients Manir, K. Sazzad
 2019
 132 S1 p. 93-94
 artikel
51 PO-072 Differentiated dysplasia, an undervalued precursor of oral squamous cell carcinoma Koljenovic, S.
 2019
 132 S1 p. 37-38
 artikel
52 PO-075 Disease-and treatment induced cachexia in locally advanced head and neck squamous cell carcinoma Willemsen, A.C.H.
 2019
 132 S1 p. 38-39
 artikel
53 PO-065 Do comorbidities affect survival in head and neck cancer treated with Cetuximab and Radiotherapy? Fanetti, G.
 2019
 132 S1 p. 34-35
 artikel
54 PO-167 3D printing of biocompatible polymers for personalized skull-base reconstruction: proof of concept Mattavelli, D.
 2019
 132 S1 p. 88-90
 artikel
55 PO-113 DW MRI as biomarker of response during RT for intermed/high risk SCC oropharynx: a feasibility study Paterson, C.
 2019
 132 S1 p. 57-58
 artikel
56 PO-123 Early changes in multiparametric imaging parameters during radiotherapy of squamous carcinoma Zborayova, K.
 2019
 132 S1 p. 63
 artikel
57 PO-154 Early mortality after Head and Neck cancer diagnosis - Who and Why? Talani, C.
 2019
 132 S1 p. 82
 artikel
58 PO-069 Efficacy of Neoadjuvant chemotherapy in locally advanced oral cancers- a randomized pilot study Shivanna, P.
 2019
 132 S1 p. 36-37
 artikel
59 PO-155 Epidemiological aspects of cancer of the nasal cavity and paranasal sinuses in the Republic Belarus Kaliadzich, Z.
 2019
 132 S1 p. 82-83
 artikel
60 PO-152 Epidemiological trends of HPV-related head and neck cancer in males: a systematic literature review Morais, E.
 2019
 132 S1 p. 81
 artikel
61 PO-151 Epidemiology aspects of laryngeal cancer in the Republic of Belarus for the period from 2008 to 2017 Kaliadzich, Z.
 2019
 132 S1 p. 80-81
 artikel
62 PO-061 Evaluating time from surgery to RT in Head and Neck cancer patients: a retrospective review of practice Paterson, C.
 2019
 132 S1 p. 33
 artikel
63 PO-130 Evaluation of a ‘dose-of-the-day’ workflow for head and neck cancer patients Berthelet, E.
 2019
 132 S1 p. 68
 artikel
64 PO-170 First reported treatment results for adenoid cystic carcinoma (ACC) of the nasopharynx Akbaba, S.
 2019
 132 S1 p. 90-91
 artikel
65 PO-096 Follow up after intra-operative assessment of resection margins in oral cavity carcinoma surgery Smits, R.
 2019
 132 S1 p. 49
 artikel
66 PO-144 Follow-up of the Head and Neck cancer patients after therapy - are we doing right things? Irjala, H.
 2019
 132 S1 p. 75
 artikel
67 PO-147 Functional outcome of postoperative IMRT after laryngeal conservative surgery Volpe, S.
 2019
 132 S1 p. 77
 artikel
68 PO-136 Haed and Neck symptoms evolution during chemo-radiotherapy: A prospective assessment Fourati, N.
 2019
 132 S1 p. 72
 artikel
69 PO-100 HDR Interstitial brachytherapy in Recurrent Head and Neck cancer: An effective Salvage option Pareek, V.
 2019
 132 S1 p. 51
 artikel
70 PO-082 Helical Tomotheray in Head and Neck Cancer: Retrospective Single Institution Experience Restrepo, C. Gil
 2019
 132 S1 p. 43
 artikel
71 PO-132 HNC patients´ experience of symptoms during radiotherapy compared to Patient-Reported Outcome tools Hollaender-Mieritz, C.
 2019
 132 S1 p. 68-69
 artikel
72 PO-127 How to optimize prophylactic lymph node irradiation in nasopharyngeal carcinoma? Fourati, N.
 2019
 132 S1 p. 66-67
 artikel
73 PO-101 HPV, tobacco smoking and specific mutations and amplifications in oropharyngeal cancer Lilja-Fischer, J.
 2019
 132 S1 p. 51-52
 artikel
74 PO-048 Hypofractionated dose escalated VMAT; comparable efficacy and less toxicity than standard CCRT in HNC Saad, E.
 2019
 132 S1 p. 25
 artikel
75 PO-181 Immunotherapy in Advanced Head and Neck Squamous Cell Cancer. Retrospective evaluation in Argentina Falco, A.
 2019
 132 S1 p. 95
 artikel
76 PO-149 Impact of Palliative Quad Shot RT on psychosocial outcomes in locally advanced HNC in MLIC’s Kanodia, R.
 2019
 132 S1 p. 79-80
 artikel
77 PO-174 Impact of weekly radiation dose on loco- regional control in elderly HNSCC patients Belgioia, L.
 2019
 132 S1 p. 92
 artikel
78 PO-089 Incidence of hypothyroidism following EBRT in Head and Neck malignancies with DVH predictors Pareek, V.
 2019
 132 S1 p. 46-47
 artikel
79 PO-063 Induction chemotherapy followed by radiotherapy for organ preservation in Oropharyngeal Cancer Fanetti, G.
 2019
 132 S1 p. 33-34
 artikel
80 PO-180 InfiltratingCD8+T-cells and PD-L1 expression as indicators for immunotherapy in sinonasal cancer López, F.
 2019
 132 S1 p. 95
 artikel
81 PO-109 Influence of HPV in the recruitment of macrophages in HNSCC Seminerio, I.
 2019
 132 S1 p. 55-56
 artikel
82 PO-062 Intensity Modulated Radiotherapy (IMRT) for Ca Nasopharynx -A Retrospective Analysis Kainickal, C.
 2019
 132 S1 p. 33
 artikel
83 PO-055 Interfractional brachial plexus movement during radical radiotherapy in Head and Neck cancer Sarwar, A.
 2019
 132 S1 p. 29-30
 artikel
84 PO-106 Intratumor heterogeneity of PD-L1 expression in Head and Neck squamous cell carcinoma Rasmussen, J.
 2019
 132 S1 p. 53-54
 artikel
85 PO-135 Laryngeal Dose correlation with Voice changes in Head and Neck cancer patients treated by VMAT Mathew, J.
 2019
 132 S1 p. 71-72
 artikel
86 PO-068 Locoregional Relapse Impact on Survival for Resected Early Stage Oral Tongue Carcinoma Labareda, M.
 2019
 132 S1 p. 36
 artikel
87 PO-143 Long-term Functional Outcome after Laryngeal Cancer Treatment Giger, R.
 2019
 132 S1 p. 75
 artikel
88 PO-077 Long-term outcome of IMRT with simultaneous integrated boost in nasopharyngeal carcinoma Linares, I.
 2019
 132 S1 p. 39-40
 artikel
89 PO-184 Low neutrophil-to-lymphocyte ratio is a negative prognosticator in oral squamous cell carcinoma Mattavelli, D.
 2019
 132 S1 p. 97
 artikel
90 PO-148 Management of bio-radiation dermatitis in HNSCC: emphasizing the role of calcium alginate dressings Bonomo, P.
 2019
 132 S1 p. 78-79
 artikel
91 PO-176 Management of head and neck non-melanoma skin cancer in the elderly Kim, H.J.
 2019
 132 S1 p. 93
 artikel
92 PO-056 Management of the N3 neck after radical chemoradiation for head and neck cancer Gujral, D.
 2019
 132 S1 p. 30
 artikel
93 PO-049 Management SCC unknown primary with contemporary diagnostic and radiotherapy techniques Paterson, C.
 2019
 132 S1 p. 25-26
 artikel
94 PO-099 Managing recurrent/metastatic head and neck cancer in the real-world: Paclitaxel plus Cetuximab Leão, I.
 2019
 132 S1 p. 51
 artikel
95 PO-091 Metronomic chemotherapy in borderline operable oral cavity squamous cell carcinoma - a pilot study Bansal, B.
 2019
 132 S1 p. 47
 artikel
96 PO-081 Multiple primary malignant neoplasms of head and neck Fessi, Z.
 2019
 132 S1 p. 42-43
 artikel
97 PO-161 Mutational profile of epithelial, non-glandular sinonasal cancers into 2 prospective clinical trials De Cecco, L.
 2019
 132 S1 p. 85-86
 artikel
98 PO-093 New combination of targeted therapies for thyroid cancer treatment Gheysen, L.
 2019
 132 S1 p. 48
 artikel
99 PO-095 Objective intra-operative assessment of resection margins in Head and Neck cancer surgery Aaboubout, Y.
 2019
 132 S1 p. 48-49
 artikel
100 PO-158 Osteoradionecrosis of the mandible after intensity modulated radiation therapy (IMRT) Aarup-Kristensen, S.
 2019
 132 S1 p. 84
 artikel
101 PO-128 Our experience of using telestration in Head and Neck cancer patients Jones, R.
 2019
 132 S1 p. 67
 artikel
102 PO-073 Outcomes and patterns of failure of oral squamous cell carcinomas treated post-operatively with IMRT Waldram, R.
 2019
 132 S1 p. 38
 artikel
103 PO-060 Outcomes from concomitant cetuximab with radiotherapy in HNSCC: A retrospective cohort study Paterson, C.
 2019
 132 S1 p. 32
 artikel
104 PO-162 Patient outcome of pencil beam-scanning proton therapy in Head and Neck adenoid cystic carcinoma Pelak, M.
 2019
 132 S1 p. 86
 artikel
105 PO-119 Pattern of failure in Head and Neckcancer after definitive RT-CT based on pre-treatment 18F-FDG PET/CT uptake Deantonio, L.
 2019
 132 S1 p. 60-61
 artikel
106 PO-118 PET/CT versus standard imaging for prediction of survival in patients with recurrent HNSCC Rohde, M.
 2019
 132 S1 p. 60
 artikel
107 PO-074 Pharyngoesophageal stricture following laryngeal-hypopharyngeal cancer treatment-management outcome Sood, R.
 2019
 132 S1 p. 38
 artikel
108 PO-165 Phase 2 study on axitinib in recurrent/metastatic salivary gland cancer of upper aerodigestive tract Locati, L.D.
 2019
 132 S1 p. 87-88
 artikel
109 PO-183 Pilot study on immunomodulation role of radiotherapy in oropharyngeal cancer: preliminary results Belgioia, L.
 2019
 132 S1 p. 96-97
 artikel
110 PO-085 Post-radiotherapy N3 nodal response in HPV positive SCC: a systematic review Virk, J.
 2019
 132 S1 p. 44-45
 artikel
111 PO-110 Potential proteomic profiling of local relapse in nasopharyngeal carcinoma from a non-endemic region Netto, E.
 2019
 132 S1 p. 56
 artikel
112 PO-153 Predicting 90-day Mortality in Locoregionally Advanced Head and Neck cancer After Curative Surgery Wu, S.
 2019
 132 S1 p. 81-82
 artikel
113 PO-057 Predicting risk of Acute Kidney Injury in head and neck cancer patients receiving chemoradiotherapy Gaito, S.
 2019
 132 S1 p. 30-31
 artikel
114 PO-104 Predictors for an improved survival in surgically treated patients - Risk stratification in OPSCC Würdemann, N.
 2019
 132 S1 p. 53
 artikel
115 PO-126 Predictors of dose differences to swallowing OARs in patients undergoing radiotherapy for HNC Noble, D.
 2019
 132 S1 p. 65-66
 artikel
116 PO-076 Predictors of postoperative pneumonia in patient undergoing oral cancer resection and its management Sood, R.
 2019
 132 S1 p. 39
 artikel
117 PO-168 Prevalence of BRAF, RAS and RET/PTC gene mutations in aggressive well-differentiated thyroid cancers Suresh, S.
 2019
 132 S1 p. 90
 artikel
118 PO-066 Primary laryngectomy vs chemoradiotherapy in T3 laryngeal cancer: a comparison of treatment outcomes Owen, A.
 2019
 132 S1 p. 35
 artikel
119 PO-182 Prognostic impact of hematological profile in oropharyngeal cancer treated with chemoradiotherapy Fanetti, G.
 2019
 132 S1 p. 95-96
 artikel
120 PO-131 Prognostic radiological features in early stage HPV positive oropharyngeal cancer Echevarria, M.
 2019
 132 S1 p. 68-69
 artikel
121 PO-070 Prognostic value of hyponatremia on metastatic or recurrent head and neck squamous cell carcinoma Moreira, C. Melo Alvim
 2019
 132 S1 p. 37
 artikel
122 PO-138 Prognostic value of tailored nutritional support in Head and Neck cancer patients undergoing treatments Tondulli, L.
 2019
 132 S1 p. 73
 artikel
123 PO-133 Prospective assessment of dysgeusia during radiotherapy for head and neck cancer Martini, S.
 2019
 132 S1 p. 70-71
 artikel
124 PO-140 Psychiatric comorbidities among tongue cancer in South Korea: A nationwide population-based study Heo, J.
 2019
 132 S1 p. 73-74
 artikel
125 PO-137 Psycho-Social Issues in Ca Head and Neck survivors with respect to physical wellbeing- A retrospective study Tiwari, A.
 2019
 132 S1 p. 72-73
 artikel
126 PO-084 Quantification of the impact of radiologic imaging revision in Head and Neck cancer Alterio, D.
 2019
 132 S1 p. 44
 artikel
127 PO-146 Radiation therapy of sinonasal carcinoma: A multidimensional study of sequelae and quality of life Sharma, M.B.
 2019
 132 S1 p. 76-77
 artikel
128 PO-078 Radio-chemotherapy for Heand and Neck cancer: retrospective comparison between weekly and three-weekly CDDP Gerardi, M.
 2019
 132 S1 p. 40
 artikel
129 PO-115 Radiomics-based prediction of response to induction chemotherapy in sinonasal cancer Bologna, M.
 2019
 132 S1 p. 59
 artikel
130 PO-080 Radiotherapy versus concurrent chemo radiotherapy in cancers of unknown primary of Head and Neck Bahl, A.
 2019
 132 S1 p. 42
 artikel
131 PO-164 Regional nodal failure after primary treatment for differentiated thyroid cancer Fanetti, G.
 2019
 132 S1 p. 87
 artikel
132 PO-094 Relocation of inadequate resection margins in the wound bed in oral cavity oncological surgery 2019
 132 S1 p. 48
 artikel
133 PO-159 Retrospective single institution analysis of the management of malignant salivary gland tumours Van Griethuysen, J.
 2019
 132 S1 p. 84-85
 artikel
134 PO-156 Risk of appearance of second and successive neoplasms in patients with a head and neck index tumor Sumarroca, A.
 2019
 132 S1 p. 83
 artikel
135 PO-112 Role of microbiota in predicting oral mucositis in head and neck cancer patients treated with IMRT Orlandi, E.
 2019
 132 S1 p. 57
 artikel
136 PO-178 Sarcopenia is a predictor for overall survival in elderly patients with head and neck cancer Chargi, N.
 2019
 132 S1 p. 94
 artikel
137 PO-139 Second Primary Cancer in Salivary gland cancer: A Nationwide Population-based Study Heo, J.
 2019
 132 S1 p. 73
 artikel
138 PO-129 Set-up errors in head and neck cancer patients undergoing IGRT. Relationship to BMI and weight loss Allajbei, A.
 2019
 132 S1 p. 67-68
 artikel
139 PO-067 Should we consider the hippocampus when optimizing the IMRT of NPC? Mnejja, W.
 2019
 132 S1 p. 35-36
 artikel
140 PO-050 Sinonasal undifferentiated carcinoma (SNUC) - endoscopic resection, chemo-radiation in 10 cases Dreyer, A.
 2019
 132 S1 p. 26
 artikel
141 PO-051 Surgery versus Radiotherapy in T1N0 glottic cancer: 10 year outcomes Ferreira, N.
 2019
 132 S1 p. 26-27
 artikel
142 PO-142 Swallowing tests and aspiration pneumonia in advanced head and neck cancer: preliminary data Lazzari, G.
 2019
 132 S1 p. 74-75
 artikel
143 PO-090 The advantages of a pectoralis major myofascial flap in reconstruction of the oropharyngeal defects Trizna, N.
 2019
 132 S1 p. 47
 artikel
144 PO-171 The "don’t eat me" signal CD47 - a therapeutic option in human anaplastic thyroid carcinoma? Schürch, C.
 2019
 132 S1 p. 91
 artikel
145 PO-141 The Effects of Biobran on Head and Neck Cancer Patients Undergoing Radiotherapy: A Double Blind RCT Flores, J.A.
 2019
 132 S1 p. 74
 artikel
146 PO-166 The impact of immunohistochemical markers of the adenoid cystic carcinoma (acc) of Head and Neck Torres, M. Laplana
 2019
 132 S1 p. 88
 artikel
147 PO-157 The Incidence and Prevalence of Head and Neck cancer in seven developed nations from 2018 to 2028 Sharma, A.
 2019
 132 S1 p. 83-84
 artikel
148 PO-169 The Phase l/ll ACCEPT Trial: Cetuximab and IMRT with Carbon Ion Boost for Adenoid Cystic Carcinoma Adeberg, S.
 2019
 132 S1 p. 90
 artikel
149 PO-097 The role of T-N tract in advanced stage tongue cancer Tagliabue, M.
 2019
 132 S1 p. 49-50
 artikel
150 PO-111 The use of a serum proteomic signature to improve HPV classification of OPSCC: A pilot study Dickinson, A.
 2019
 132 S1 p. 56-57
 artikel
151 PO-124 Three-dimensional radiation dose of osteoradionecrosis in oropharyngeal cancer receiving IMRT Mohamed, A.S.R.
 2019
 132 S1 p. 63-64
 artikel
152 PO-052 T3 Laryngeal SCC: a mono- institutional retrospective analysis of different therapeutic approaches Bacigalupo, A.
 2019
 132 S1 p. 27-28
 artikel
153 PO-150 Transpositional facial artery myomucosal island flap for reconstruction of early tongue cancer Kim, D.H.
 2019
 132 S1 p. 80
 artikel
154 PO-160 Tumor and retropharyngeal nodal GTVs prognostic role in unresectable non-glandular sinonasal cancers Ferella, L.
 2019
 132 S1 p. 85
 artikel
155 PO-105 UICC TNM 8th Edition Staging in Oropharyngeal Cancer: Validation in a UK Single Centre Cohort 2019
 132 S1 p. 53
 artikel
156 PO-120 Up-front F18-FDG PET/CT in suspected salivary gland carcinoma Westergaard-Nielsen, M.
 2019
 132 S1 p. 61
 artikel
157 PO-079 Up-front surgery and adjuvant RT of paranasal sinuses carcinoma: single center retrospective study Colaco, R. Da Silva
 2019
 132 S1 p. 40-41
 artikel
158 PO-121 Use of radiomics in the recurrence patterns after IMRT for Head and Neck cancer: a preliminary study Li, S.
 2019
 132 S1 p. 61-62
 artikel
159 PO-114 Variability in target volume delineation in Head and Neck cancer: Results of a national study Van der Veen, J.
 2019
 132 S1 p. 58-59
 artikel
160 PO-125 Visibility study for GTVp delineation for Head and Neck following recent consensus guidelines Whittam, S.
 2019
 132 S1 p. 65
 artikel
161 PO-145 Voice outcome in patients with early glottic cancer following radiotherapy versus laser microsurgery Altaibej, A.
 2019
 132 S1 p. 75-76
 artikel
162 SP-004 Against the motion Lambin, P.
 2019
 132 S1 p. 6
 artikel
163 SP-047 Against the motion Faivre, S.
 2019
 132 S1 p. 24-25
 artikel
164 SP-033 Bio-endoscopy Peretti, G.
 2019
 132 S1 p. 19
 artikel
165 SP-015 Current status of immunotherapy in Head and Neck cancer Licitra, L.
 2019
 132 S1 p. 12
 artikel
166 SP-034 3Dimension Reconstruction in the Head and Neck Parmar, S.
 2019
 132 S1 p. 19-20
 artikel
167 SP-039 Discussion: How to improve survivorship: patient’s point of view Steinbacher, A.
 2019
 132 S1 p. 20
 artikel
168 SP-028 Early response evaluation in radiation therapy driven larynx organ preservation Dietz, A.
 2019
 132 S1 p. 16
 artikel
169 SP-003 For the motion Gregoire, V.
 2019
 132 S1 p. 6
 artikel
170 SP-046 For the motion: This house believes that immunotherapy is going to replace chemotherapy Harrington, K.
 2019
 132 S1 p. 24
 artikel
171 SP-037 How to make use of the AHNS survivorship guidelines? Sacco, A.
 2019
 132 S1 p. 20
 artikel
172 SP-002 Immune landscape in Head and Neck cancer Brandau, S.
 2019
 132 S1 p. 6
 artikel
173 SP-014 Immuno-score Galome, J.
 2019
 132 S1 p. 11
 artikel
174 SP-036 Integration of imaging and radiotherapy innovation: Head and neck radiotherapy applications Fuller, C.
 2019
 132 S1 p. 20
 artikel
175 SP-016 Integration of immunotherapy with radiotherapy in Head and Neck cancer Huber, P.
 2019
 132 S1 p. 12
 artikel
176 SP-026 Modern IMRT planning, how high can we push the bar? Hansen, C. Rønn
 2019
 132 S1 p. 15
 artikel
177 SP-027 New developments in proton therapy in Head and Neck cancer Thomson, D.
 2019
 132 S1 p. 15-16
 artikel
178 SP-035 New developments in sentinel node biopsy De Bree, R.
 2019
 132 S1 p. 20
 artikel
179 SP-001 New insights into the molecular landscape of Head and Neck cancer Brakenhoff, R.
 2019
 132 S1 p. 6
 artikel
180 SP-012 Pembrolizumab in the first line treatment of recurrent and/or metastatic head and neck cancer Burtness, B.
 2019
 132 S1 p. 11
 artikel
181 SP-018 Pushing the limits in Head and Neck robotic surgery Simon, C.
 2019
 132 S1 p. 12
 artikel
182 SP-038 Self-management and eHealth to facilitate supportive care in head and neck cancer patients Leeuw, I. Verdonck-de
 2019
 132 S1 p. 20
 artikel
183 SP-017 SNUC: a sustainable concept? Franchi, A.
 2019
 132 S1 p. 12
 artikel
184 SP-025 The fourth major salivary gland and its clinical implications Vougel, V.
 2019
 132 S1 p. 15
 artikel
185 SP-013 TNM8: How has the dust settled one year later? O’Sullivan, B.
 2019
 132 S1 p. 11
 artikel
186 Title page 2019
 132 S1 p. i
 artikel
                             186 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland